Corcept Therapeutics

Region Manager, Central Plains

Remote

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Region Manager

Employment Type:

Location Type:

Salary: $190,000 - $215,000 (Pay may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.)


Position Overview

Corcept is a leader in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). We have discovered over 1,000 proprietary cortisol modulators and received FDA approval for Korlym® (mifepristone), the first approved treatment for hypercortisolism (Cushing’s syndrome). Our team is dedicated to advancing the possibilities of cortisol modulation to treat serious diseases, with over 30 ongoing studies across various disease areas including endocrinology, oncology, metabolism, and neurology.

The Region Manager will lead a team of Clinical Specialists (CS) and provide consistent direction for the execution of sales and marketing strategies within their assigned region.


Responsibilities

  • Formulate sales strategies and analyze regional performance.
  • Engage with key customers by developing and implementing strategies to support sales growth.
  • Provide ongoing coaching and development for the Clinical Specialists team.
  • Develop and maintain customer relationships with key executives and decision-makers in all key accounts.
  • Participate in and contribute to commercial team planning sessions, representing customer and sales team needs, and driving business-building plans.
  • Act as a local liaison and collaborator, building consensus on strategies and tactics that drive business results.
  • Operate within compliance guidelines at all times.

Preferred Skills, Qualifications, and Technical Proficiencies

  • Proven success in leading a sales team across a large geography.
  • Experience in endocrinology, orphan disease, or other specialized markets is a plus.
  • Strong clinical acumen.
  • Ability to analyze sales and relevant market data to formulate strategic plans.
  • Strong ability to collaborate and work cross-functionally.
  • Required to travel by car and plane at least 80% of the time.

Preferred Education and Experience

  • Master’s Degree in a life science or related field, or equivalent experience.
  • Must maintain a driving record in accordance with Corcept vehicle policy.

Application Instructions

Applicants must be currently authorized to work in the United States on a full-time basis.


Company Information

Corcept is an Equal Opportunity Employer. We appreciate the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.

For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information, and for an explanation of your rights and choices regarding your personal information, please refer to our Privacy Notice.

Website: https://www.corcept.com/

Important Note: Corcept will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview process. Please be vigilant in checking that communication is in fact coming from Corcept, even when third-party tools are used for job advertising.


#LI-Remote

Skills

Sales Strategy
Performance Analysis
Customer Relationship Management
Team Leadership
Endocrinology
Orphan Disease
Sales Management
Marketing Strategy

Corcept Therapeutics

Develops cortisol modulators for medical conditions

About Corcept Therapeutics

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing various health issues. Their main product, Korlym, is used to treat Cushing's syndrome, a condition caused by too much cortisol. Korlym was approved by the FDA in 2012 and is the first medication specifically for this disorder. Corcept stands out from competitors by having a strong emphasis on research and development, having discovered over 1,000 unique cortisol modulators. The company aims to expand its range of treatments while also providing educational resources to healthcare professionals and patients to improve understanding and care for cortisol-related conditions.

Menlo Park, CaliforniaHeadquarters
1998Year Founded
$39.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Remote Work Options
Flexible Work Hours

Risks

Teva's antitrust lawsuit could lead to legal expenses and market share loss.
Heavy reliance on Korlym makes Corcept vulnerable to market fluctuations.
Recent investments may pressure Corcept for short-term financial performance, impacting R&D.

Differentiation

Corcept specializes in cortisol modulation, a niche with few direct competitors.
Korlym is the first FDA-approved treatment for Cushing's syndrome, a significant market advantage.
Corcept's extensive R&D has led to the discovery of over 1,000 selective cortisol modulators.

Upsides

Increased interest in cortisol therapies for mental health boosts Corcept's R&D prospects.
Advancements in drug delivery systems could enhance Corcept's product efficacy.
The FDA's fast-track designation supports Corcept's innovative cortisol-related treatments.

Land your dream remote job 3x faster with AI